• 1. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 2. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 3. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 4. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 5. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes

Professional Introduction to Compound with CAS No 2707-23-5 and Product Name: 2-Chloro-N-4-(trifluoromethyl)phenylacetamide

The compound with the CAS number 2707-23-5 and the product name 2-Chloro-N-4-(trifluoromethyl)phenylacetamide represents a significant area of interest in the field of pharmaceutical chemistry. This compound, characterized by its unique structural and chemical properties, has garnered attention for its potential applications in drug development and medicinal chemistry. The presence of both chloro and trifluoromethyl substituents in its molecular structure imparts distinct reactivity and functionality, making it a valuable candidate for further exploration.

In recent years, the pharmaceutical industry has witnessed a surge in the development of novel compounds that incorporate fluorine atoms, particularly in the form of trifluoromethyl groups. These groups are known to enhance metabolic stability, binding affinity, and overall pharmacological activity of drug candidates. The 2-Chloro-N-4-(trifluoromethyl)phenylacetamide molecule exemplifies this trend, as it combines the benefits of chloro substitution with the potent effects of the trifluoromethyl moiety.

One of the most compelling aspects of this compound is its versatility in synthetic chemistry. The chloro group serves as a versatile handle for further functionalization, allowing chemists to explore a wide range of derivatives. This flexibility is particularly useful in medicinal chemistry, where structural modifications can significantly impact biological activity. Moreover, the phenylacetamide core is a well-established scaffold in drug design, known for its role in various therapeutic areas.

Recent studies have highlighted the importance of 2-Chloro-N-4-(trifluoromethyl)phenylacetamide in the development of novel therapeutic agents. For instance, researchers have investigated its potential as an intermediate in the synthesis of kinase inhibitors, which are crucial in treating cancers and inflammatory diseases. The trifluoromethyl group, in particular, has been shown to improve the binding affinity of these inhibitors to their target enzymes, thereby enhancing their efficacy.

Another area where this compound has shown promise is in the development of antimicrobial agents. The combination of chloro and trifluoromethyl substituents is known to confer enhanced activity against resistant bacterial strains. This is particularly relevant in today's healthcare landscape, where antibiotic resistance poses a significant challenge. By leveraging the structural features of 2-Chloro-N-4-(trifluoromethyl)phenylacetamide, scientists are exploring new strategies to combat this issue.

The synthesis of 2-Chloro-N-4-(trifluoromethyl)phenylacetamide involves a series of well-defined chemical transformations that highlight its synthetic accessibility. The process typically begins with the preparation of 4-trifluoromethylbenzoic acid, which is then converted into its corresponding acetyl chloride derivative. This intermediate undergoes nucleophilic substitution with amide-forming reagents to yield the final product. The reaction conditions are carefully optimized to ensure high yields and purity, making it suitable for industrial-scale production.

From a mechanistic standpoint, the reactivity of 2-Chloro-N-4-(trifluoromethyl)phenylacetamide can be attributed to the electronic properties of its substituents. The chloro group is an excellent leaving group, facilitating various substitution reactions under mild conditions. Meanwhile, the trifluoromethyl group exerts an electron-withdrawing effect through hyperconjugation and induction, influencing both acid-base properties and reaction pathways.

In conclusion, 2-Chloro-N-4-(trifluoromethyl)phenylacetamide represents a promising compound with significant potential in pharmaceutical research and drug development. Its unique structural features make it a valuable building block for synthesizing novel therapeutic agents targeting various diseases. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in shaping the future of medicinal chemistry.

• 16143-84-3(3,5-Bis(Trifluoromethyl)Acetanilide)
• 790-75-0(N-3,5-bis(Trifluoromethyl)phenyl-2-chloroacetamide)
• 36040-85-4(2-Chloro-N-3-(trifluoromethyl)phenylpropanamide)
• 3792-04-9(2-chloro-N-2-(trifluoromethyl)phenylacetamide)
• 1939-29-3(3-Trifluoromethyl-2,2,2-Trichloroacetanilide 95%)
• 351-38-2(2-chloro-N-3-(trifluoromethyl)phenylacetamide)
• 349-97-3(4'-(Trifluoromethyl)acetanilide)
• 2837-61-8(2,2-Dichloro-n-[3-(trifluoromethyl)phenyl]acetamide)
• 351-36-0(3-(Trifluoromethyl)acetanilide)
• 77485-81-5(Acetamide, 2-chloro-N-[2-methyl-6-(trifluoromethyl)phenyl]-)